| Pathogenic variants in the myosin chaperone UNC-45B cause progressive myopathy with eccentric cores S Donkervoort, CE Kutzner, Y Hu, X Lornage, J Rendu, T Stojkovic, ... The American Journal of Human Genetics 107 (6), 1078-1095, 2020 | 28 | 2020 |
| Myostatin: a circulating biomarker correlating with disease in myotubular myopathy mice and patients C Koch, S Buono, A Menuet, A Robé, S Djeddi, C Kretz, R Gomez-Oca, ... Molecular Therapy Methods & Clinical Development 17, 1178-1189, 2020 | 16 | 2020 |
| Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies S Djeddi, D Reiss, A Menuet, S Freismuth, J de Carvalho Neves, ... Molecular Therapy 29 (8), 2514-2534, 2021 | 15 | 2021 |
| Pathophysiological effects of overactive STIM1 on murine muscle function and structure R Silva-Rojas, AL Charles, S Djeddi, B Geny, J Laporte, J Böhm Cells 10 (7), 1730, 2021 | 13 | 2021 |
| Differential impact of ubiquitous and muscle dynamin 2 isoforms in muscle physiology and centronuclear myopathy R Gómez-Oca, E Edelweiss, S Djeddi, M Gerbier, X Massana-Muñoz, ... Nature Communications 13 (1), 6849, 2022 | 8 | 2022 |
| TCF1–LEF1 co-expression identifies a multipotent progenitor cell (TH2-MPP) across human allergic diseases R Kratchmarov, S Djeddi, G Dunlap, W He, X Jia, CM Burk, T Ryan, ... Nature Immunology, 1-14, 2024 | 2 | 2024 |
| Increased epithelial mTORC1 activity in chronic rhinosinusitis with nasal polyps GX Huang, NR Hallen, M Lee, K Zheng, X Wang, MV Mandanas, S Djeddi, ... bioRxiv, 2023 | 2 | 2023 |
| PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells Z Chen, SAA Ghavimi, M Wu, J McNamara, O Barreiro, D Maridas, ... JCI insight 8 (24), 2023 | 1 | 2023 |
| ORAI1 inhibition as an efficient preclinical therapy for tubular aggregate myopathy and Stormorken syndrome R Silva-Rojas, L Pérez-Guàrdia, A Simon, S Djeddi, S Treves, A Ribes, ... JCI insight 9 (6), 2024 | | 2024 |
| Increased glycolysis and cellular crosstalk in eosinophilic chronic rhinosinusitis with nasal polyps GX Huang, MV Mandanas, S Djeddi, D Fernandez-Salinas, ... Frontiers in Immunology 15, 1321560, 2024 | | 2024 |
| mTORC1 regulates airway epithelial cytokine generation in CRSwNP G Huang, N Hallen, M Lee, K Zheng, X Wang, M Mandanas, S Djeddi, ... Journal of Allergy and Clinical Immunology 153 (2), AB151, 2024 | | 2024 |
| Rhinovirus infection of airway epithelial cells uncovers the non-ciliated subset as a likely driver of genetic susceptibility to childhood-onset asthma S Djeddi, D Fermandez-Salinas, G Huang, V Aguiar, C Mohanty, ... medRxiv, 2024.02. 02.24302068, 2024 | | 2024 |
| P57 ORAI1 inhibition as a preclinical therapy for tubular aggregate myopathy (TAM) and Stormorken syndrome (STRMK) R Silva-Rojas, L Pérez-Guàrdia, A Simon, S Djeddi, S Treves, J Laporte, ... Neuromuscular Disorders 33, S73, 2023 | | 2023 |
| Identification de mécanismes pathologiques et thérapeutiques des myopathies congénitales par analyse intégrée d'omiques S Djeddi Strasbourg, 2021 | | 2021 |
| CONGENITAL MYOPATHIES–CENTRONUCLEAR MYOPATHIES: EP. 29 Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies S Djeddi, D Reiss, A Menuet, S Freismuth, J de Carvalho Neves, ... Neuromuscular Disorders 31, S58, 2021 | | 2021 |
